AstraZeneca

We have been awarded two 2024 Freezer Challenge awards from My Green Lab and the I2SL: International Institute for Sustainable Laboratories, recognising our commitment to sustainable science. These include the Winning Streak Award for Biotech & Pharmaceuticals for exceeding our energy savings from the 2023 Freezer Challenge, and the Top Small Lab Award – Pharmaceutical & Biotech Sector for our Gothenburg Regional HBS Centre. #WhatScienceCanDo

Despite the standard of care, many severe asthma patients can experience debilitating symptoms.      We are continuously striving to achieve our ambition to address the vast challenges and unmet medical needs that patients with chronic respiratory diseases face today. 

Endometrial cancer is the sixth most common cancer in women worldwide, with incidence rates rising. Conversation and education are critical to changing this future. Understanding the symptoms – and challenging each other as a community to raise open and honest awareness – is how we are going to make a difference against this disease. #EndometrialCancer #UterineCancer #WombCancer

Our approach to sustainable science is transforming R&D practices to deliver life-changing medicines across the globe. From our state-of-the-art Discovery Centre (DISC) in Cambridge, to our labs in Gothenburg and Gaithersburg, we're driving health innovation with a lower environmental footprint. Our efforts are contributing to a 98% reduction in our Scope 1 and 2 greenhouse gas emissions from a 2015 baseline. Discover how we’re making progress toward our Ambition Zero Carbon targets and building a healthier future for people and the planet https://learn.az/6049lEz1L #WhatScienceCanDo #NetZero

Our latest article dives into how cutting-edge tools like generative AI enhance data analysis, fuel clinical trials and bring us a step closer to our ultimate goal - better medicine for patients. Find out more about this exciting journey towards scientific innovation: https://learn.az/6048YCzv2 #GenerativeAI #DataScience

📣 Introducing our 2024 Young Health Programme Impact Fellows 📣 These inspiring young leaders are working to build a healthier future for young people, society, and the planet. Each Impact Fellow will receive: 🎓 A fully-funded scholarship to the @One Young World Summit in Montréal 📕 Access to an award-winning MBA Essentials course 🚀 Ongoing network and development opportunities Learn more: https://learn.az/6048Y0Dmr #InternationalYouthDay #YoungHealthProgramme #OYW24

The Powering Breast Cancer Progress grant programme, in collaboration with the Charities Aid Foundation (CAF), is focused on expanding patient navigation services to underserved populations across the globe. We have received and are currently reviewing applications from more than 50 countries, reinforcing that underserved patient populations exist across all economies. We look forward to announcing the grant awardees later this year. #PatientNavigation #BreastCancerSupport

Our Centre for Genomics Research is at the forefront of multi-omic innovation - leveraging bioinformatic, machine learning, and AI approaches to decode disease biology. Discover more about multi-omics in drug discovery and how we harness insights to better understand and develop treatments for complex diseases in this article from Drug Discovery World: https://learn.az/6046cCj9m

As a part of our focus on Sustainability, we responded to the US President's Emergency Plan for Adaptation and Resilience (PREPARE) with a commitment to help health systems across Africa adapt to the climate crisis. Pam Cheng, our EVP, Global Operations & IT and Chief Sustainability Officer, joined US government and business leaders to share how Healthy Heart Africa is supporting health system resilience in the face of climate change. Through the expansion of our flagship Healthy Heart Africa programme in nine countries, we will work with global and local partners to strengthen health systems so that they can address the health impacts of climate change, with a focus on heart and kidney diseases. Explore how we’re taking action: https://learn.az/6046cNRHs

We’ve announced our H1 and Q2 results, with the strength of our underlying business providing confidence to upgrade our full-year 2024 guidance. Total Revenue and Core EPS are now anticipated to grow by a mid teens percentage at CER. Thank you to the AstraZeneca team around the world who continue to unlock the power of what science can do for people, society and the planet. #AZN #WhatScienceCanDo